Literature DB >> 35845340

Association of the Comprehensive ESRD Care Model with Treatment Adherence.

Richard A Hirth1,2, Tammie Nahra2,3, Jonathan H Segal2,4, Joseph Gunden2,3, Grecia Marrufo5, Brighita Negrusa5, Gregory Boyer6, Amy Jiao1,2,3, Kathryn Sleeman2,3, Claudia Dahlerus2,4, Jennifer Wiens5, Darin Ullman5, Kelsey Bacon5, Daniel Strubler5, Rebecca Braun5, Ariana Ackerman5, Yi Li2,3.   

Abstract

Background: Poor adherence to scheduled dialysis treatments is common and can cause adverse clinical and economic outcomes. In 2015, the Centers for Medicare and Medicaid Innovation launched the Comprehensive ESRD Care (CEC) Model, a novel modification of the Accountable Care Organization framework. Many model participants reported efforts to increase dialysis adherence and promptly reschedule missed treatments.
Methods: With Medicare databases covering 2014-2019, we used difference-in-differences models to compare treatment adherence among patients aligned to 1037 CEC facilities relative to those aligned to matched comparison facilities, while accounting for their differences at baseline. Using dates of service, we identified patients who typically received three weekly treatments and the days when treatments typically occurred. Skipped treatments were defined as days when the patient was not hospitalized but did not receive an expected treatment, and rescheduled treatments as days when a patient who had skipped their previous treatment received an additional treatment before their next expected treatment date.
Results: Patients in the CEC Model had higher odds of attending as-scheduled sessions relative to the comparison group, although the effect was only marginally significant (OR, 1.02; 95% CI, 1.00 to 1.04, P=0.08). Effects were stronger among females (OR, 1.03; 95% CI, 1.00 to 1.06, P=0.06) than males (OR, 1.01; 95% CI, 0.98 to 1.04, P=0.49), and among those aged <70 years (OR, 1.02; 95% CI, 1.00 to 1.05, P=0.04) than those aged ≥70 years (OR, 1.00; 95% CI, 0.96 to 1.04, P=0.96). The CEC was associated with higher odds of rescheduled sessions (OR, 1.09; 95% CI, 1.05 to 1.14, P<0.001). Effects were significant for both sexes, but were larger among males (OR, 1.11; 95% CI, 1.05 to 1.18, P<0.001) than females (OR, 1.07; 95% CI, 1.02 to 1.13, P=0.01), and effects were significant among those <70 years (OR, 1.12; 95% CI, 1.07 to 1.17, P<0.001), but not those ≥70 years (OR, 0.99; 95% CI, 0.92 to 1.07, P=0.80). Conclusions: The CEC Model is intended to incentivize strategies to prevent costly interventions. Because poor dialysis adherence may precipitate hospitalizations or other adverse events, many CEC Model participants encouraged adherence and promptly rescheduled missed treatments as strategic priorities. This study suggests these efforts were a success, although the absolute magnitudes of the effects were modest.
Copyright © 2022 by the American Society of Nephrology.

Entities:  

Keywords:  ESKD; ESKD patients; basic science; comprehensive health care; dialysis; dialysis treatment adherence; skipped treatment; treatment adherence

Mesh:

Year:  2021        PMID: 35845340      PMCID: PMC9255885          DOI: 10.34067/KID.0006132021

Source DB:  PubMed          Journal:  Kidney360        ISSN: 2641-7650


  14 in total

1.  Medicare Accountable Care Organizations and Antidepressant Use by Patients With Depression.

Authors:  Alisa B Busch; Haiden A Huskamp; Amanda R Kreider; J Michael McWilliams
Journal:  Psychiatr Serv       Date:  2017-07-17       Impact factor: 3.084

2.  Adherence barriers to chronic dialysis in the United States.

Authors:  Kevin E Chan; Ravi I Thadhani; Franklin W Maddux
Journal:  J Am Soc Nephrol       Date:  2014-04-24       Impact factor: 10.121

3.  Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.

Authors:  J Michael McWilliams; Mehdi Najafzadeh; William H Shrank; Jennifer M Polinski
Journal:  JAMA Cardiol       Date:  2017-09-01       Impact factor: 14.676

4.  Kidney Disease Population Health Management in the Era of Accountable Care: A Conceptual Framework for Optimizing Care Across the CKD Spectrum.

Authors:  Mallika L Mendu; Sushrut S Waikar; Sandhya K Rao
Journal:  Am J Kidney Dis       Date:  2017-01-26       Impact factor: 8.860

5.  Missed Hemodialysis Treatments: International Variation, Predictors, and Outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Issa Al Salmi; Maria Larkina; Mia Wang; Lalita Subramanian; Hal Morgenstern; Stefan H Jacobson; Raymond Hakim; Francesca Tentori; Rajiv Saran; Takashi Akiba; Natalia A Tomilina; Friedrich K Port; Bruce M Robinson; Ronald L Pisoni
Journal:  Am J Kidney Dis       Date:  2018-08-23       Impact factor: 8.860

6.  Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS.

Authors:  Rajiv Saran; Jennifer L Bragg-Gresham; Hugh C Rayner; David A Goodkin; Marcia L Keen; Paul C Van Dijk; Kiyoshi Kurokawa; Luis Piera; Akira Saito; Shunichi Fukuhara; Eric W Young; Philip J Held; Friedrich K Port
Journal:  Kidney Int       Date:  2003-07       Impact factor: 10.612

7.  Noncompliance in hemodialysis: predictors and survival analysis.

Authors:  J E Leggat; S M Orzol; T E Hulbert-Shearon; T A Golper; C A Jones; P J Held; F K Port
Journal:  Am J Kidney Dis       Date:  1998-07       Impact factor: 8.860

8.  Behavioral compliance with dialysis prescription in hemodialysis patients.

Authors:  P L Kimmel; R A Peterson; K L Weihs; S J Simmens; D H Boyle; D Verme; W O Umana; J H Veis; S Alleyne; I Cruz
Journal:  J Am Soc Nephrol       Date:  1995-04       Impact factor: 10.121

9.  In-center hemodialysis absenteeism: prevalence and association with outcomes.

Authors:  Kathryn S Gray; Dena E Cohen; Steven M Brunelli
Journal:  Clinicoecon Outcomes Res       Date:  2017-05-24

10.  Impact of Rescheduling a Missed Hemodialysis Treatment on Clinical Outcomes.

Authors:  Dena E Cohen; Kathryn S Gray; Carey Colson; David B Van Wyck; Francesca Tentori; Steven M Brunelli
Journal:  Kidney Med       Date:  2019-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.